Apyx Medical Corporation (APYX), an energy technology company that designs and manufactures electrosurgical equipment and medical devices, reported fourth quarter 2025 financial results.
Apyx Medical Corporation (APYX) posted a Q4 2025 loss of $0.03 per share. The company generated $19.2M in revenue for the quarter. The company operates through two segments: Advanced Energy and Original Equipment Manufacturing (OEM), serving customers in the United States and internationally.
A detailed analysis of Apyx Medical Corporation’s quarter follows shortly on AlphaStreet.
This article was generated using AlphaStreet’s proprietary financial analysis technology and reviewed by our editorial team.